Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis.
Bach Xuan TranGiang H HaGiang T VuLong H NguyenCarl A LatkinKalpana NathanRoger S McIntyreCyrus Su Hui HoWilson Wai Sun Wai Sun TamRoger Chun-Man HoPublished in: International journal of environmental research and public health (2019)
This scientometric analysis represents comprehensive evidence on the popularity and change in prospects of biological treatments for MDD from 1988 to 2017. The popularity of SSRI peaked between 1998 and 2002, when their efficacy, tolerability and safety profile allowed them to replace the TCAs and MAOIs. While the newer neurostimulation therapies are gaining momentum, the popularity of ECT has sustained.